Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus

摘要

Described herein are methods and compositions for the treatment of spinal disorders mediated by nucleus pulposus. The compositions can include a soluble cytokine receptor and/or a TNF-α blocking antibody.